Taken together, the evidence for both TDP-43 loss-of-nuclear function and toxic gain-of-cytoplasmic function suggest the continued use of rNLS8 mice as a robust model for preclinical testing of interventions for ALS/FTLD-TDP. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.